Patent · US Active

Crystalline forms of a menin inhibitor

US12410184B2 · kind B2 · utility

0Cited by

6References

35Claims

0Family size

Assignee

Kura Oncology, Inc. · US

Inventors

Roger P. Bakale · Summit, US
Craig Michael Bowe · Encinitas, US
Dipanjan Sengupta · Goleta, US
Patricia Andres · West Lafayette, US
Xiaohu Deng · San Diego, US

Key dates

Filing date	Sep 6, 2024
Grant date	Sep 9, 2025
Priority date	—
Expiry date	Sep 6, 2044

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K31/519
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Described herein are crystalline forms of (S)-4-methyl-5-((4-((2-(methylamino)-6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)methyl)-1-(2-(4-(methylsulfonyl)piperazin-1-yl)propyl)-1H-indole-2-carbonitrile or solvate thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.